The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
744
LONG-TERM EFFICACY AND SAFETY OF INTRAVENOUS TULISOKIBART IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE OPEN-LABEL EXTENSION PERIOD OF THE PHASE 2 ARTEMIS-UC STUDY
Date
May 5, 2025
Explore related products in the following collection:
